Fundraising Fox

Doug Treco, Ph.D.

Investor

Advisor at Lightstone Ventures

About

Advisor to Lightstone Ventures and co-founder of Ra Pharmaceuticals, serving as CEO until its 2020 acquisition by UCB. Doug also co-founded Transkaryotic Therapies (acquired by Shire in 2005) and served as Entrepreneur-in-Residence at Morgenthaler Ventures.

Colleagues at Lightstone Ventures

Brendan Kelly
Principal at Lightstone Ventures
Brendan Kelly, Ph.D.
Principal at Lightstone Ventures
Caroline Gaynor
Partner at Lightstone Ventures
Christina Isacson
Partner at Lightstone Ventures
Christina Isacson, Ph.D.
Partner at Lightstone Ventures
Doug Treco
Advisor at Lightstone Ventures
Frank D. Lee
Advisor at Lightstone Ventures
H. Martin Seidel
Advisor at Lightstone Ventures